- Poster presentation
- Open Access
First experiences in the treatment of juveniles and idiopathic scoliosis with SpineCor braces
- A Sarchioto1
© Sarchioto; licensee BioMed Central Ltd. 2013
Published: 3 June 2013
The standardized treatment of juvenile, and adolescent, idiopathic scoliosis is accepted everywhere: physiotherapy for curves until 15-20° Cobb, rigid brace between 20 and 30-35° Cobb, cast between 30 and 40-45° Cobb and surgery over 45° Cobb.
The aim of this work is to verify the efficacy and effectiveness of the SpineCor dynamic brace, in juvenile and adolescent idiopathic scoliosis with curves between 20 and 50° Cobb.
All patients (range of age 5 to 15 years) were treated with a SpineCor dynamic brace. All braces were ordered, fitted and used, following the standard canons of the appropriate procedure. A photographic control was carried out, just after fitting, a clinical control in a month, a clinical and photographic in three months, and a clinical, photographic and radiographic in six months.
Over 90% of patients had a very important change in their posture and cosmetic appearance. None of them left the treatment.
The SpineCor dynamic brace used is efficient and effective. Because it does not limit any movement, and allows practicing all sports, (but swimming), and dance, and since it is virtually invisible under clothing, no patient has complained of the treatment. Both patients and parents were satisfied. This good result allows, and encourages, us to continue in using this brace.
- Coillard C, Circo A, Rivard CH: A new concept for the non-invasive treatment of Adolescent Idiopathic Scoliosis: the Corrective Movement principle integrated in the SpineCor System. Disabil Rehabil Assist Technol. 2008, 3 (3): 112-119. 10.1080/17483100801903913.View ArticlePubMedGoogle Scholar
- Vachon V, C C, Zabjek K, Rhalmi S, Rivard C-H: Analyse de survie d'une cohorte de 365 patients scoliotiques traitÃ©s par le corset SpineCor Ã. 2006, l'HÃ´pital Sainte-JustineGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.